- Home
- INTS vs TRSG Comparison
INTS vs TRSG Comparison
Compare INTS & TRSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- TRSG
- Stock Information
- Founded
- INTS 2012
- TRSG 1996
- Country
- INTS United States
- TRSG Singapore
- Employees
- INTS N/A
- TRSG N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- TRSG
- Sector
- INTS Health Care
- TRSG
- Exchange
- INTS Nasdaq
- TRSG NYSE
- Market Cap
- INTS 30.8M
- TRSG 25.8M
- IPO Year
- INTS 2023
- TRSG 2024
- Fundamental
- Price
- INTS $0.54
- TRSG $1.79
- Analyst Decision
- INTS Strong Buy
- TRSG
- Analyst Count
- INTS 3
- TRSG 0
- Target Price
- INTS $8.50
- TRSG N/A
- AVG Volume (30 Days)
- INTS 362.2K
- TRSG 28.5K
- Earning Date
- INTS 05-20-2025
- TRSG 12-31-2024
- Dividend Yield
- INTS N/A
- TRSG N/A
- EPS Growth
- INTS N/A
- TRSG N/A
- EPS
- INTS N/A
- TRSG N/A
- Revenue
- INTS N/A
- TRSG $14,441,864.00
- Revenue This Year
- INTS N/A
- TRSG N/A
- Revenue Next Year
- INTS N/A
- TRSG N/A
- P/E Ratio
- INTS N/A
- TRSG N/A
- Revenue Growth
- INTS N/A
- TRSG 9.34
- 52 Week Low
- INTS $0.50
- TRSG $1.00
- 52 Week High
- INTS $5.28
- TRSG $6.96
- Technical
- Relative Strength Index (RSI)
- INTS 18.34
- TRSG N/A
- Support Level
- INTS $0.55
- TRSG N/A
- Resistance Level
- INTS $0.59
- TRSG N/A
- Average True Range (ATR)
- INTS 0.12
- TRSG 0.00
- MACD
- INTS -0.02
- TRSG 0.00
- Stochastic Oscillator
- INTS 4.71
- TRSG 0.00
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.